A two-compartment model of VEGF distribution in the mouse

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Yen, Phillip ^a   Finley, Stacey D ^a   Engel Stefanini, Marianne O ^a   Popel, Aleksander S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; NEUROPILIN 1; PROTEIN VEGF120; PROTEIN VEGF164; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; ANGIOGENESIS INHIBITOR; ANGIOGENIC PROTEIN; PEPTIDE FRAGMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ARTICLE; CAPILLARY PERMEABILITY; CELL COMPARTMENTALIZATION; CELL MEMBRANE TRANSPORT; CELL SURFACE; COMPARTMENT MODEL; COMPUTER MODEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; EXPERIMENTAL DESIGN; MACROMOLECULE; PARENCHYMA; PLASMA CLEARANCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SENSITIVITY ANALYSIS; SKELETAL MUSCLE; VALIDITY; ANIMAL; BIOLOGICAL MODEL; BLOOD; METABOLISM; MOUSE; PROTEIN BINDING; TISSUE DISTRIBUTION;

ANIMALIA; MUS;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; BLOOD; MICE; MODELS, BIOLOGICAL; NEUROPILIN-1; PEPTIDE FRAGMENTS; PROTEIN BINDING; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 80555154416     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027514     Document Type: Article

References (78)

1. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N, (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
2. Nakamura M, Abe Y, Tokunaga T, (2002) Pathological significance of vascular endothelial growth factor A isoform expression in human cancer. Pathol Int 52: 331-339.
3. Roskoski R Jr, (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 62: 179-213.
4. Ferrara N, Davis-Smyth T, (1997) The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25.
5. Ferrara N, Gerber HP, LeCouter J, (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
6. Stefanini MO, Qutub AA, Gabhann FM, Popel AS, (2011) Computational models of VEGF-associated angiogenic processes in cancer. Math Med Biol.
7. Mac Gabhann F, Popel AS, (2007) Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. Am J Physiol Heart Circ Physiol 292: H459-474.
8. Stefanini MO, Wu FT, Mac Gabhann F, Popel AS, (2010) Increase of plasma VEGF after intravenous administration of bevacizumab is predicted by a pharmacokinetic model. Cancer Res 70: 9886-9894.
9. Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, et al. (2010) VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model. Am J Physiol Heart Circ Physiol 298: H2174-2191.
10. Testa U, Pannitteri G, Condorelli GL, (2008) Vascular endothelial growth factors in cardiovascular medicine. J Cardiovasc Med (Hagerstown) 9: 1190-1221.
11. Fox J, (2007) The Mouse in Biomedical Research. New York Academic Press.
12. Liu G, Qutub AA, Vempati P, Mac Gabhann F, Popel AS, (2011) Module-based multiscale simulation of angiogenesis in skeletal muscle. Theor Biol Med Model 8: 6.
13. Qutub AA, Liu G, Vempati P, Popel AS, (2009) Integration of angiogenesis modules at multiple scales: from molecular to tissue. Pac Symp Biocomput pp. 316-327.
14. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, et al. (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605-12608.
15. Folkman J, (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31.
16. Rudge JS, Holash J, Hylton D, Russell M, Jiang S, et al. (2007) Inaugural Article: VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade. Proc Natl Acad Sci U S A 104: 18363-18370.
17. Leighl NB, Raez LE, Besse B, Rosen PJ, Barlesi F, et al. (2010) A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung. J Thorac Oncol 5: 1054-1059.
18. Stefanini MO, Wu FT, Mac Gabhann F, Popel AS, (2008) A compartment model of VEGF distribution in blood, healthy and diseased tissues. BMC Syst Biol 2: 77.
19. Stefanini MO, Wu FT, Mac Gabhann F, Popel AS, (2009) The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling. PLoS Comput Biol 5: e1000622.
20. Wu FT, Stefanini MO, Mac Gabhann F, Popel AS, (2009) Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models. Methods Enzymol 467: 461-497.
21. Wu FT, Stefanini MO, Mac Gabhann F, Popel AS, (2009) A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap. PLoS One 4: e5108.
22. Yang J, Ratovitski T, Brady JP, Solomon MB, Wells KD, et al. (2001) Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev 60: 351-361.
23. Hoff J, (2000) Methods of Blood Collection in the Mouse. Lab Animal 29: 7.
24. Sassen A, Reuter AM, Kennes F, (1968) Determination of plasma volume in the mouse with screened iodine-labelled proteins. Experientia 24: 1203-1204.
25. Hinghofer-Szalkay H, Greenleaf JE, (1987) Continuous monitoring of blood volume changes in humans. J Appl Physiol 63: 1003-1007.
26. Mendez J, Kollias J, (1977) Diet and starvation on the composition and calculated density of fat-free body mass. J Appl Physiol 42: 731-734.
27. Sheff MF, Zacks SI, (1982) Interstitial space of mouse skeletal muscle. J Physiol 328: 507-519.
28. Hagstrom L, Agbulut O, El-Hasnaoui-Saadani R, Marchant D, Favret F, et al. (2010) Epo is relevant neither for microvascular formation nor for the new formation and maintenance of mice skeletal muscle fibres in both normoxia and hypoxia. J Biomed Biotechnol 2010.
29. Medeiros A, Vanzelli AS, Rosa KT, Irigoyen MC, Brum PC, (2008) Effect of exercise training and carvedilol treatment on cardiac function and structure in mice with sympathetic hyperactivity-induced heart failure. Braz J Med Biol Res 41: 812-817.
30. Olfert IM, Howlett RA, Tang K, Dalton ND, Gu Y, et al. (2009) Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol 587: 1755-1767.
31. Tang K, Breen EC, Gerber HP, Ferrara NM, Wagner PD, (2004) Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics 18: 63-69.
32. Wagatsuma A, Tamaki H, Ogita F, (2005) Capillary supply and gene expression of angiogenesis-related factors in murine skeletal muscle following denervation. Exp Physiol 90: 403-409.
33. Wong LE, Garland T Jr, Rowan SL, Hepple RT, (2009) Anatomic capillarization is elevated in the medial gastrocnemius muscle of mighty mini mice. J Appl Physiol 106: 1660-1667.
34. Leuenberger PM, Babel J, Full C, (1970) Width of retinal capillary basement membrane of spiny mice (Acomy cahirinus) at various ages. Doc Ophthalmol 28: 191-200.
35. Mathieu-Costello O, (1989) Muscle capillary tortuosity in high altitude mice depends on sarcomere length. Respir Physiol 76: 289-302.
36. Mayrovitz HN, (1992) Skin capillary metrics and hemodynamics in the hairless mouse. Microvasc Res 43: 46-59.
37. Paques M, Tadayoni R, Sercombe R, Laurent P, Genevois O, et al. (2003) Structural and hemodynamic analysis of the mouse retinal microcirculation. Invest Ophthalmol Vis Sci 44: 4960-4967.
38. Olewniczak S, Chosia M, Kolodziej B, Kwas A, Kram A, et al. (2003) Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma. Pol J Pathol 54: 53-59.
39. Olewniczak S, Chosia M, Kwas A, Kram A, Domagala W, (2002) Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women. Pol J Pathol 53: 183-188.
40. Haas TL, Duling BR, (1997) Morphology favors an endothelial cell pathway for longitudinal conduction within arterioles. Microvasc Res 53: 113-120.
41. Sher J, Cardasis C, (1976) Skeletal muscle fiber types in the adult mouse. Acta Neurol Scand 54: 45-56.
42. Liu JX, Hoglund AS, Karlsson P, Lindblad J, Qaisar R, et al. (2009) Myonuclear domain size and myosin isoform expression in muscle fibres from mammals representing a 100,000-fold difference in body size. Exp Physiol 94: 117-129.
43. van der Meer SF, Jaspers RT, Jones DA, Degens H, (2010) The time course of myonuclear accretion during hypertrophy in young adult and older rat plantaris muscle. Ann Anat 193: 56-63.
44. Bruusgaard JC, Liestol K, Gundersen K, (2006) Distribution of myonuclei and microtubules in live muscle fibers of young, middle-aged, and old mice. J Appl Physiol 100: 2024-2030.
45. Soukup T, Zacharova G, Smerdu V, (2002) Fibre type composition of soleus and extensor digitorum longus muscles in normal female inbred Lewis rats. Acta Histochem 104: 399-405.
46. Cuthbertson RA, Mandel TE, (1986) Anatomy of the mouse retina. Capillary basement membrane thickness. Invest Ophthalmol Vis Sci 27: 1653-1658.
47. Man M, Adams E, (1975) Basement membrane and interstitial collagen content of whole animals and tissues. Biochem Biophys Res Commun 66: 9-16.
48. Podrazky V, Sedmerova V, (1966) Densities of collagen dehydrated by some organic solvents. Experientia 22: 792.
49. Hicks P, Rolsten C, Brizzee D, Samorajski T, (1983) Age-related changes in rat brain capillaries. Neurobiol Aging 4: 69-75.
50. Gibson JG, Evans WA, (1937) Clinical Studies of the Blood Volume. II. The Relation of Plasma and Total Blood Volume to Venous Pressure, Blood Velocity Rate, Physical Measurements, Age and Sex in Ninety Normal Humans. J Clin Invest 16: 317-328.
51. Truskey G, Yuan F, Katz D, (2004) Transport phenomena in biological systems. Upper Saddle River, NJ Pearson Prentice Hall.
52. Feng D, Nagy JA, Brekken RA, Pettersson A, Manseau EJ, et al. (2000) Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 48: 545-556.
53. Imoukhuede PI, Popel AS, (2011) Quantification and cell-to-cell variation of vascular endothelial growth factor receptors. Exp Cell Res 317: 955-965.
54. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N, (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267: 26031-26037.
55. Filion RJ, Popel AS, (2004) A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors. Ann Biomed Eng 32: 645-663.
56. Garlick DG, Renkin EM, (1970) Transport of large molecules from plasma to interstitial fluid and lymph in dogs. Am J Physiol 219: 1595-1605.
57. Venturoli D, Rippe B, (2005) Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol 288: F605-613.
58. Holash J, Davis S, Papadopoulos N, Croll SD, Ho L, et al. (2002) VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A 99: 11393-11398.
59. Vempati P, Popel AS, Mac Gabhann F, (2011) Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis. BMC Syst Biol 5: 59.
60. Ng YS, Rohan R, Sunday ME, Demello DE, D'Amore PA, (2001) Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 220: 112-121.
61. Ee LC, Zheng S, Yao L, Tso P, (2000) Lymphatic absorption of fatty acids and cholesterol in the neonatal rat. Am J Physiol Gastrointest Liver Physiol 279: G325-331.
62. Wassmer B, Augenstein U, Ronai A, de Looze S, von Deimling O, (1988) Lymph esterases of the house mouse (Mus musculus)-II. The role of esterase-2 in fat resorption. Comp Biochem Physiol B 91: 179-185.
63. Wachsberger PR, Burd R, Cardi C, Thakur M, Daskalakis C, et al. (2007) VEGF Trap in combination with radiotherapy improves tumor control in U87 glioblastoma. Int J Radiat Oncol Biol Phys 67: 1526-1537.
64. Daly T, (2009) VEGF-Binding Fusion Proteins. USA Regeneron Pharmaceuticals, Inc.
65. North Central Cancer Treatment Group (2007) Phase II Trial of VEGF Trap in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and/or Taxane. NCI.
66. Coleman TF, Li Y, (1994) On the Convergence of Reflective Newton Methods for Large-Scale Nonlinear Minimization Subject to Bounds. Mathematical Programming 67: 189-224.
67. Coleman TF, Li Y, (1996) An Interior, Trust Region Approach for Nonlinear Minimization Subject to Bounds. SIAM Journal on Optimization 6: 418-445.
68. Kenakin TP, (2009) 12.4.3. In: Press/Elsevier A, editors. A pharmacology primer: theory, applications, and methods Amsterdam Academic Press/Elsevier.
69. Tissot van Patot MC, Leadbetter G, Keyes LE, Bendrick-Peart J, Beckey VE, et al. (2005) Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. J Appl Physiol 98: 1626-1629.
70. Kleinheinz J, Jung S, Wermker K, Fischer C, Joos U, (2010) Release kinetics of VEGF165 from a collagen matrix and structural matrix changes in a circulation model. Head Face Med 6.
71. Serini G, Ambrosi D, Giraudo E, Gamba A, Preziosi L, et al. (2003) Modeling the early stages of vascular network assembly. EMBO J 22: 1771-1779.
72. Chen RR, Silva EA, Yuen WW, Brock AA, Fischbah C, et al. (2007) Integrated approach to designing growth factor delivery systems. FASEB J 21: 3896-3903.
73. Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, et al. (2010) A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med 14: 528-552.
74. Favier B, Alam A, Barron P, Bonnin J, Laboudie P, et al. (2006) Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 108: 1243-1250.
75. Rygaard J, Povlsen CO, (1969) Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol Microbiol Scand 77: 758-760.
76. Tokunaga T, Kijima H, Oshika Y, Fukushima Y, Abe Y, et al. (1998) Aberrant isoform of vascular endothelial growth factor 189 expression is correlated with xenotransplantability of human esophageal cancer. Oncol Rep 5: 1115-1118.
77. Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, et al. (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111: 1227-1233.
78. Hernandez N, Torres SH, Finol HJ, Vera O, (1999) Capillary changes in skeletal muscle of patients with essential hypertension. Anat Rec 256: 425-432.